IMI2-2020-23-01 Returning Clinical Trial Data to Study Participants within a GDPR compliant and approved ethical framework
IMI2-2020-23-02 Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance
IMI2 2020-23-03 A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
IMI2-2020-23-04 Optimal treatment for patients with solid tumours in Europe through Artificial Intelligence
IMI2-2020-23-05 Shortening the path to rare disease diagnosis by using newborn genetic screening and digital technologies
IMI2-2020-23-06 Behavioural Model of Factors Affecting Patient Adherence
Restricted Call to maximise impact of IMI2 JU objectives and scientific priorities
SC1-PHE-CORONAVIRUS-2020-2E -Networking of existing EU and international cohorts of relevance to COVID-19
SC1-PHE-CORONAVIRUS-2020-2D -Pan-European COVID-19 cohorts
SC1-PHE-CORONAVIRUS-2020-2C -Behavioural, social and economic impacts of the outbreak response
SC1-PHE-CORONAVIRUS-2020-2B -Medical technologies, Digital tools and Artificial Intelligence (AI) analytics to improve surveillance and care at high Technology Readiness Levels (TRL)
SC1-PHE-CORONAVIRUS-2020-2A -Repurposing of manufacturing for vital medical supplies and equipment.
IMI2 - 21: Development of therapeutics and diagnostics combatting coronavirus infections
IMI2 - 20 - 01: Early diagnosis, prediction of radiographic outcomes and development of rational, personalised treatment strategies to improve long-term outcomes in psoriatic arthritis
IMI2 - 20 - 02: Innovations to accelerate vaccine development and manufacture
IMI2 - 20 - 03: Academia and industry united innovation and treatment for tuberculosis (UNITE4TB)
IMI2 - 20 - 04: Tumour plasticity
IMI2 - 20 - 05: Proton versus photon therapy for oesophageal cancer - a trimodality strategy
IMI2 - 20 - 06: Handling of protein drug products and stability concerns
SC1-DTH-13-2020: Implementation research for scaling up and transfer of innovative solutions involving digital tools for people-centred care
SC1-DTH-12-2020: Use of Real-World Data to advance research on the management of complex chronic conditions
SC1-BHC-35-2020: Creation of a European wide sustainable network for harmonised large-scale clinical research studies for infectious diseases
SC1-BHC-34-2020: New approaches for clinical management and prevention of resistant bacterial infections in high prevalence settings
SC1-BHC-33-2020: Addressing low vaccine uptake
SC1-BHC-24-2020: Healthcare interventions for the management of the elderly multimorbid patient
SC1-BHC-20B-2020: Public procurement of innovative solutions (PPI) for diagnostics for infectious diseases
SC1-BHC-20A-2020: Pre-commercial procurement (PCP) for integrated care solutions
SC1-BHC-17-2020: Global Alliance for Chronic Diseases (GACD) - Prevention and/or early diagnosis of cancer
SC1-BHC-11-2020: Advancing the safety assessment of chemicals without the use of animal testing
SC1-BHC-08-2020: New interventions for Non-Communicable Diseases
SC1-BHC-06-2020: Digital diagnostics – developing tools for supporting clinical decisions by integrating various diagnostic data
SME-2 SME instrument phase 2
Bando Fabbrica Intelligente, Agrifood, Scienze della Vita
Fast Track to Innovation (FTI)
PON Ricerca & Innovazione 2014-2020: Fondo dei Fondi - Miur
Opportunità EUROPA
Opportunità ITALIA